well, what timing - after I mentioned this yesterday! A shame...

well, what timing - after I mentioned this yesterday!

A shame the entire saga, but at least this puts the whole thing to rest & an extra 100k is small, but something. MLA can now focus completely on the human business with no distractions.

I'd suspect cash is incredibly tight in Medivet and unless Delk has managed to tap other investors then there are probably ongoing cash issues, quite likely that without the capital injection Medivet will be passed by other stem-cell offerings. So as a MLA holder I'll go with the silver lining and hope we dodged a giant cash vacuum!


all IMO, DYOR etc....